GM Advisory Group’s AstraZeneca AZN Stock Holding History

GM Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$475K	Buy	+2,421	New	+$467K	0.02%	238
2025 Q4	–	Sell	-2,423	Closed	-$372K	–	346
2025 Q3	$372K	Hold	2,423	–	–	0.02%	222
2025 Q2	$339K	Hold	2,423	–	–	0.02%	226
2025 Q1	$356K	Hold	2,423	–	–	0.02%	202
2024 Q4	$317K	Sell	2,423 -61	-2%	-$8.54K	0.02%	203
2024 Q3	$387K	Buy	2,484 +61	+3%	+$9.85K	0.02%	181
2024 Q2	$378K	Sell	2,423 -37	-2%	-$5.57K	0.02%	171
2024 Q1	$333K	Sell	2,460 -48	-2%	-$6.36K	0.02%	177
2023 Q4	$338K	Buy	2,508 +85	+4%	+$11.1K	0.03%	167
2023 Q3	$328K	Buy	+2,423	New	+$331K	0.03%	150

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

GM Advisory Group's AZN Position: Q1 2026 in Review

GM Advisory Group opened a new position in AstraZeneca (AZN) in Q1 2026: 2,421 shares worth $475K. The stake represents 0.02% of the portfolio and ranks #238 among its holdings. This is a return to the name: GM Advisory Group previously reported a position in AZN as recently as Q3 2025.

GM Advisory Group first reported a position in AZN in Q3 2023 and has held it in 10 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

GM Advisory Group held 2,421 shares of AstraZeneca worth $475K as of Q1 2026.
AstraZeneca was a new GM Advisory Group position in Q1 2026.
AstraZeneca made up 0.02% of GM Advisory Group's portfolio in Q1 2026, its #238 holding.
GM Advisory Group first reported a position in AstraZeneca in Q3 2023 and has held it in 10 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.